Items where Author is "Daru, J."
Article
Sweeney, L., Lanz, D., Daru, J. , Rasijeff, A. M. P., Khanom, F., Thomas, A., Harden, A. 
ORCID: 0000-0002-8621-5066 & Green, L. (2022).
Deferred consent in emergency obstetric research: findings from qualitative interviews with women and recruiters in the ACROBAT pilot trial for severe postpartum haemorrhage.
BMJ Open, 12(5),
article number e054787.
doi: 10.1136/bmjopen-2021-054787
Amaefule, C. E., Drymoussi, Z., Gonzalez Carreras, F. J. , Pardo Llorente Del Carmen, M., Lanz, D., Dodds, J., Sweeney, L., Pizzo, E., Thomas, A., Heighway, J., Daru, J., Sobhy, S., Poston, L., Khalil, A., Myers, J., Harden, A. ORCID: 0000-0002-8621-5066, Hitman, G., Khan, K. S., Zamora, J., Pérez, T., Huda, M. S. B. & Thangaratinam, S. (2022).
Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study.
BMJ Open, 12(3),
article number e050110.
doi: 10.1136/bmjopen-2021-050110
Amaefule, C. E., Bolou, A., Drymoussi, Z. , Gonzalez Carreras, F. J., Pardo Llorente, M. D. C., Lanz, D., Dodds, J., Sweeney, L., Pizzo, E., D'Amico, M., Thomas, A., Heighway, J., Daru, J., Sobhy, S., Robson, J., Sanghi, A., Zamora, J., Harden, A. ORCID: 0000-0002-8621-5066, Hitman, G., Khan, K., Pérez, T., Huda, M. S. B. & Thangaratinam, S. (2020).
Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: a protocol for a randomised, placebo-controlled, double-blind feasibility trial—Optimising health outcomes with Metformin to prevent diAbetes After pregnancy (OMAhA).
BMJ Open, 10(5),
article number e036198.
doi: 10.1136/bmjopen-2019-036198
Amaefule, C. E., Drymoussi, Z., Dodds, J. , Sweeney, L., Pizzo, E., Daru, J., Robson, J., Poston, L., Khalil, A., Myers, J., Harden, A. ORCID: 0000-0002-8621-5066, Hitman, G. A., Khan, K., Zamora, J., Huda, M. S. B. & Thangaratinam, S. (2018).
Effectiveness and acceptability of myo-inositol nutritional supplement in the prevention of gestational diabetes (EMmY): a protocol for a randomised, placebo-controlled, double-blind pilot trial..
BMJ Open, 8(9),
doi: 10.1136/bmjopen-2018-022831